Biography
Özge oversees product development at Massive Bio, ensuring our platform evolves to meet the real needs of patients and clinicians navigating the cancer treatment landscape. She is committed to creating intuitive, patient-centric features that simplify access to clinical trials and treatment information. She bridges the gap between user feedback, clinical evidence, and technology innovation.
Tumore Ai Polmoni Si Guarisce
MARCH 2024
Peritoneal Cancer
MARCH 2024
7 Sintomi Del Cancro Ai Polmoni
FEBRUARY 2024
Cardiac Amyloidosis
FEBRUARY 2024
Tumore Al Fegato Sintomi
FEBRUARY 2024
Mieloma Multiplo
FEBRUARY 2024
Linfoma non Hodgkin
FEBRUARY 2024
Cosa sapere sul linfoma a cellule mantellari?
NOVEMBER 2023
L’Importanza della Rilevazione Precoce: Riconoscere i Segnali della Leucemia Linfoblastica Acuta nell’Infanzia
OCTOBER 2023
Massive Bio lancia la campagna “Ho il cancro”.
SEPTEMBER 2023
Comprendere il Carcinoma Polmonare ROS1-Positivo: Differenze e Prospettive
AUGUST 2023
Late-Stage Multiple Myeloma
JUNE 2023
First Signs of Colon Cancer
JUNE 2022
Chronic Lymphocytic Leukemia vs Multiple Myeloma
JUNE 2022
What Is ROS1-Positive Non-small Cell Lung Cancer?
APRIL 2022
Stem Cell Transplant for Myelofibrosis
APRIL 2022
What Is a Biomarker? How Is It Used in Clinical Trials?
FEBRUARY 2022
What are the Differences Between Small Cell and Non-Small Cell Lung Cancer?
FEBRUARY 2022
Chronic Myelogenous Leukemia Treatment
JANUARY 2022
Diffuse Large B-Cell Lymphoma Stage 4
JANUARY 2022
Chemotherapy for Non-Hodgkin’s Lymphoma
JANUARY 2022
Myelofibrosis Prognosis
AUGUST 2021
What Causes Pancreatic Cancer?
JUNE 2021
Access of Right Treatments to the Right Patients in Oncology
FEBRUARY 2021
No articles match your search.